Validation studies for depyrogenation processes must focus on: Response:

Question

Options

• ATemperature and duration
• BEmployee comfort levels
• CPackaging design
• DSocial media impact

• A
  74% (23)
• B
  3% (1)
• C
  6% (2)
• D
  16% (5)

Explanation

Depyrogenation validation must demonstrate that the process reliably destroys pyrogens (bacterial endotoxins) to safe levels, and this is proven by measuring temperature and duration - the two physical parameters that directly determine lethal exposure to heat. Regulatory standards (like the FDA's requirement for a 3-log reduction in endotoxin) are validated by confirming that critical temperature thresholds (typically ≥250°C for dry heat) are maintained for sufficient time throughout the load.

Why the distractors are wrong:

• B (Employee comfort): Entirely irrelevant to process efficacy or safety validation - this is an engineering/microbial concern, not an occupational one.
• C (Packaging design): Packaging is a separate consideration for product integrity; it does not govern whether pyrogens are destroyed.
• D (Social media impact): Has no place in pharmaceutical process validation of any kind.

Memory tip: Think of depyrogenation like baking - what kills the "bad stuff" is heat + time. Validation always asks: "Was it hot enough, for long enough?" If you anchor to those two physical variables, option A will always stand out.

No community discussion yet for this question.